New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report

32Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The 2019 new coronavirus (SARS-CoV-2) is a novel respiratory virus which has increasingly spread all over the world. Although the predominant clinical presentation is represented by respiratory symptoms, neurological manifestation of SARS-CoV-2 is being increasingly recognized. In the present report, we present a case of post SARS-CoV-2 autoimmune encephalitis associated with a new-onset refractory status epilepticus (NORSE).

Cite

CITATION STYLE

APA

Dono, F., Carrarini, C., Russo, M., De Angelis, M. V., Anzellotti, F., Onofrj, M., & Bonanni, L. (2021). New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report. Neurological Sciences, 42(1), 35–38. https://doi.org/10.1007/s10072-020-04846-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free